← All Inari Medical, INC filings

Inari Medical, INC Form 4 insider transactions

NARI
Inari Medical, INC
Form 4: Inari Medical CEO Andrew Hykes Sells Shares Under 10b5-1 Trading Plan
Inari Medical's CEO, Andrew Hykes, sold 3,000 shares of common stock at $50 per share on May 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical Director William Hoffman Sells 60,000 Shares
Director William Hoffman of Inari Medical, Inc. executed a sale of 60,000 shares of common stock on May 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Rebecca Chambers Reports Stock Sale
Director Rebecca Chambers sold 964 shares of Inari Medical (NARI) at $45.39 per share on May 20, 2024, according to a Form 4 filing.
NARI
Inari Medical, INC
Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan
Director William Hoffman of Inari Medical, Inc. sold shares of common stock on May 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical CFO Mitch Hill Executes Stock Option and Sells Shares Under 10b5-1 Plan
Inari Medical's CFO, Mitch C. Hill, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan
Director William Hoffman sold shares of Inari Medical (NARI) on May 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Robert Warner Reports Stock Transaction
Director Robert Warner of Inari Medical, Inc. reports acquisition and disposal of common stock on April 24, 2024.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Catherine Szyman Acquires Shares and Receives Restricted Stock Units
Director Catherine M. Szyman of Inari Medical, Inc. reports acquisition of common stock and grant of restricted stock units.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Jonathan Root Reports Stock Transaction
Director Jonathan Root of Inari Medical, Inc. reports acquisition of restricted stock units and updates beneficial ownership.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Donald Milder Reports Acquisition of Restricted Stock Units
Director Donald Milder reports acquiring 4,126 restricted stock units of Inari Medical, Inc. at a price of $42.41 on April 24, 2024.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Dana G. Mead, Jr. Reports Stock Transactions
Director Dana G. Mead, Jr. of Inari Medical, Inc. reports acquisition of restricted stock units and disposal of common stock.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Cynthia Lucchese Reports Acquisition of 4,126 Shares
Director Cynthia Lucchese reports acquiring 4,126 shares of Inari Medical, Inc. common stock at $42.41 per share on April 24, 2024.
NARI
Inari Medical, INC
Form 4: Inari Medical Director William Hoffman Reports Stock Transaction
Director William Hoffman reports acquisition and disposal of Inari Medical (NARI) stock on April 24, 2024.
NARI
Inari Medical, INC
Form 4: Inari Medical Director Rebecca Chambers Reports Acquisition of Restricted Stock Units
Director Rebecca Chambers reports acquiring 4,126 restricted stock units of Inari Medical at $42.41 per unit on April 24, 2024, and disposing of 10,908 common stock.
NARI
Inari Medical, INC
Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan
Director William Hoffman sold 1,451 shares of Inari Medical (NARI) at $40 per share on April 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical CFO Mitch Hill Executes Stock Option and Sells Shares Under 10b5-1 Plan
Inari Medical's CFO, Mitch Hill, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical CEO Andrew Hykes Reports Changes in Beneficial Ownership
Andrew Hykes, CEO of Inari Medical, reports the disposal of shares to cover tax obligations related to vesting restricted share units.
NARI
Inari Medical, INC
Form 4: Inari Medical CFO Mitch Hill Reports Stock Disposals to Cover Tax Obligations
Mitch C. Hill, CFO of Inari Medical, Inc., reports the disposal of common stock to cover tax obligations related to vesting restricted share units.
NARI
Inari Medical, INC
Form 4: Inari Medical Director William Hoffman Reports Stock Disposals to Cover Tax Obligations
Director William Hoffman of Inari Medical, Inc. reports disposing of common stock to cover tax obligations related to vesting restricted share units.
NARI
Inari Medical, INC
Form 4: Inari Medical's Chief Medical Officer, Thomas Tu, Reports Changes in Beneficial Ownership
Thomas Tu, Chief Medical Officer of Inari Medical, reports the disposal of shares to cover tax obligations related to vesting restricted share units.
NARI
Inari Medical, INC
Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan
Director William Hoffman of Inari Medical, Inc. executed sales of common stock on March 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NARI
Inari Medical, INC
Form 4: Inari Medical CFO Mitch Hill Executes Stock Options and Sells Shares Under 10b5-1 Plan
Mitch C. Hill, CFO of Inari Medical, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.